Maternal and Neonatal Outcomes Associated With Preeclampsia and Gestational Diabetes Mellitus: A Retrospective Cohort

Abdullah Umer1, Saadia Kanwal2, Angbeen Ahmad3

  • 1Radiology, Combined Military Hospital, Lahore, Lahore, PAK.

Cureus
|July 17, 2025
PubMed

Background Preeclampsia and gestational diabetes mellitus (GDM) are common pregnancy complications associated with significant maternal and neonatal morbidity. Objectives This study aims to evaluate and compare maternal and neonatal outcomes in pregnancies complicated by preeclampsia, GDM, and the coexistence of both conditions. Methods This retrospective observational study included 230 pregnant women who delivered at Shalamar Hospital, Lahore, Pakistan, between January 2023 and December 2024. The participants were divided into three groups: preeclampsia only (n = 80), GDM only (n = 75), and both conditions (n = 75). Results The coexistence of preeclampsia and GDM was associated with the highest rates of cesarean section (82.7%, n = 62), preterm birth (46.7%, n = 35), neonatal intensive care unit (NICU) admission (49.3%, n = 37), and neonatal hypoglycemia (18.7%, n = 14). Maternal complications, including intensive care unit (ICU) admission (10.7%, n = 8) and postpartum hemorrhage (9.3%, n = 7), were also more frequent in this group. Logistic regression confirmed that combined preeclampsia and GDM independently predicted adverse outcomes such as cesarean delivery (odds ratio {OR}: 2.4), NICU admission (OR: 2.1), and preterm birth (OR: 1.9). Conclusion It is concluded that the co-occurrence of preeclampsia and GDM significantly worsens both maternal and neonatal outcomes compared to either condition alone. Early diagnosis, multidisciplinary management, and targeted interventions are crucial to mitigating these risks and improving perinatal care.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
697
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K